Related Experiment Videos
Mesangial cell-predominant gene, megsin
Reiko Inagi1, Toshio Miyata, Toshiyuki Imasawa
1Institute of Medical Sciences and Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Summary
Researchers discovered megsin, a novel serine protease inhibitor (serpin), linked to kidney diseases like IgA nephropathy. Overexpressing megsin in mice caused key kidney lesions, suggesting its role in disease progression.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Mesangial cell abnormalities are central to kidney diseases such as IgA nephropathy and diabetic nephropathy.
- The specific molecular mechanisms driving mesangial expansion and proliferation remain incompletely understood.
Purpose of the Study:
- To identify novel genes involved in mesangial cell function and kidney disease pathogenesis.
- To investigate the role of the newly identified gene, megsin, in the development of mesangial lesions.
Main Methods:
- Utilized a 3'-directed regional cDNA library from cultured human mesangial cells to identify novel genes.
- Analyzed megsin RNA and protein expression levels in patient samples.
- Generated and studied human megsin transgenic mice to assess its pathophysiological significance.
Main Results:
- Identified and characterized a novel gene, megsin, predominantly expressed in mesangial cells.
- Found that megsin expression is upregulated in patients with IgA nephropathy and diabetic nephropathy.
- Demonstrated that genetic manipulation of megsin in mice leads to mesangial expansion and increased mesangial cell number.
Conclusions:
- Megsin is a novel serine protease inhibitor (serpin) implicated in kidney disease.
- Megsin expression correlates with key pathological features of mesangial expansion and proliferation.
- Megsin plays a significant role in the pathogenesis of glomerular diseases.